Analysis of the bHLH transcription factors Olig1 and Olig2 in brain tumors

Journal of Neuro-Oncology

Volumn 67, Issue 3, 2004, Pages 265-271

  Aguirre Cruz, Lucinda ^a,c   Mokhtari, Karima ^b   Hoang Xuan, Khê ^a,b   Marie, Yannick ^a   Criniere, Emmanuelle ^a   Taillibert, Sophie ^b   Lopes, Manuel ^b   Delattre, Jean Yves ^a,b   Sanson, Marc ^a,b  

^a INSERM   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c NATIONAL INSTITUTE OF NEUROLOGY AND NEUROSURGERY   (Mexico)

Author keywords

bHLH; Gliomas; Olig1; Olig2; Oligodendrogliomas

Indexed keywords

ACID PROTEIN; HELIX LOOP HELIX PROTEIN; NEUROFILAMENT PROTEIN; OLIGODENDROCYTE TRANSCRIPTION FACTOR 2; PROTEOLIPID PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR OLIG1; UNCLASSIFIED DRUG; BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; DNA BINDING PROTEIN; NERVE PROTEIN; OLIG1 PROTEIN, HUMAN; OLIG2 PROTEIN, HUMAN;

ARTICLE; ASTROCYTE; ASTROCYTOMA; BRAIN LYMPHOMA; BRAIN TISSUE; BRAIN TUMOR; CANCER GRADING; CELL MATURATION; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DIFFERENTIAL DIAGNOSIS; GENE EXPRESSION; GENETIC ANALYSIS; GLIOBLASTOMA; GLIOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; IN SITU HYBRIDIZATION; MAJOR CLINICAL STUDY; NERVE CELL; OLIGODENDROGLIA; OLIGODENDROGLIOMA; PROTEIN EXPRESSION; STAINING; WORLD HEALTH ORGANIZATION; DNA PROBE; GENETICS; METABOLISM; PATHOLOGY;

ASTROCYTES; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; BRAIN NEOPLASMS; DNA PROBES; DNA-BINDING PROTEINS; HELIX-LOOP-HELIX MOTIFS; HUMANS; IN SITU HYBRIDIZATION; NERVE TISSUE PROTEINS; NEURONS; OLIGODENDROGLIA;

EID: 2942731495     PISSN: 0167594X     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:NEON.0000024190.56750.81     Document Type: Article

References (20)

1. Coons SW, Johnson PC, Scheithauer BW, Yates AJ, Pearl DK: Improving diagnostic accuracy and interobserver concordance in the classification and grading of primary gliomas. Cancer 79: 1381-1393, 1997
2. Popko B, Pearl DK, Walker DM, Comas TC, Baerwald KD, Burger PC, Scheithauer BW, Yates AJ: Molecular markers that identify human astrocytomas and oligodendrogliomas. J Neuropathol Exp Neurol 61: 329-338, 2002
3. Shoshan Y, Nishiyama A, Chang A, Mork S, Barnett GH, Cowell JK, Trapp BD, Staugaitis SM. Expression of oligodendrocyte progenitor cell antigens by gliomas: implications for the histogenesis of brain tumors. Proc Natl Acad Sei USA 96: 10361-10366, 1999
4. Lu QR, Yuk D, Alberta JA, Zhu Z, Pawlitzky I, Chan J, McMahon AP, Stiles CD, Rowitch DH: Sonic hedgehog-regulaled oligodendrocyte lineage genes encoding bHLH proteins in the mammalian central nervous system. Neuron 25: 317-329, 2000
5. Zhou Q, Wang S, Anderson DJ: Identification of a novel family of oligodendrocyte lineage-specific basic helix-loop-helix transcription factors. Neuron 25: 331-343, 2000
6. Marie Y, Sanson M, Mokhtari K, Leuraud P, Kujas M, Delattre JY, Poirier J, Zalc B, Hoang-Xuan K: OLIG2 as specific marker of oligodendroglial tumour cells. Lancet 358: 298-300, 2001
7. Lu QR, Park JK, Noll E, Chan JA, Alberta J, Yuk D, Alzamora MG, Louis DN, Stiles CD, Rowitch DH, Black PM: Oligodendrocyte lineage genes (OLIG) as molecular markers for human and brain tumors. Proc Natl Acad Sci USA 98: 10851-10856, 2001
8. Kleihues P, Louis DN, Scheithauer BW, Rorke LB, Reifenberger G, Burger PC, Cavenee WK: The WHO clasification of tumors of the nervous system. J Neuropathol Exp Neurol 61: 215-225, 2002
9. Strähle U, Blader P, Adam J, Ingham P. A simple and efficient procedure for non-isotopic in situ hybridization to sectioned material. Trends Genet 10: 75-76, 1994
10. Myat A, Henrique D, Ish-Horowicz D, Lewis J: A chick homologue of Serrate and its relationship with Notch and Delta homologues during central neurogenesis. Dev. Biol 174: 233-247, 1996
11. Spassky N, Goujet-Zalc C, Parmantier E. Olivier C. Martinez S, Ivanova A, Ikenaka K, Macklin W, Cerruti I. Zalc B, Thomas ?JD: Multiple restricted origin of oligodendrocytes. J Neurosci 18: 8331-8343, 1998
12. Daumas-Duport C, Varlet P, Tucker ML, Beuvon F. Cervera P, Chodkiewicz JP: Oligodendrogliomas. Part 1: patterns of growth hostological diagnosis clinical and imaging correlations: a study of 153 cases. J Neuro-Oncol 34: 37-59, 1997
13. Burger PC: What is an oligodendroglioma? Brain Pathol 12: 257-259, 2002
14. He J, Mokhtari K, Sanson M, Marie Y, Kujas M, Huguet S, Leuraud P, Capelle L, Delattre JY, Poirier J, Hoang-Xuan K: Glioblastomas with an oligodendroglial componant: a pathological and molecular study. J Neuropathol Exp Neurol 60: 863-871, 2001
15. Lu QR, Cai L, Rowitch D, Cepko CL, Stiles CD: Ectopic expression of Olig1 promotes oligodendrocyte formation and reduces neuronal survival in developing mouse cortex: Nat Neurosci 4: 973-974, 2001
16. Sun T, Echelard Y, Lu R, Yuk DI, Kaing S, Rowitch DH: Rowitch DH: Olig bHLH protein interact with homeodomain protein to regulate cell late acquisation in progenitors of the ventral neural tube. Curr Biol 11: 1413-1420, 2001
17. Lu QR, Sun T, Zhu Z, Ma N, Garcia M, Stiles CD, Rowitch DH: Common developmental requirement for Olig function indicates a motor neuron/oligodendrocyte connection. Cell 109: 75-86, 2002
18. Zhou Q, Anderson DJ: The bHLH transcription factors OLIG2 and OLIG1 couple neuronal and glial subtype specification. Cell 109: 61-73, 2002
19. Wang J, Jani-Sait SN, Escalon EA, Carroll AJ, de Jong PJ, Kirsch IR, Aplan PD: The t(14;21)(q11.2;q22) chromosomal translocation associated with T-cell acute lymphoblastic leukemia activates the BHLHB1 gene. Proc Natl Acad Sci USA 97: 3497-3502, 2000
20. Herblot S, Aplan PD, Hoang T: Gradient of E2A activity in B-cell development. Mol Cell Biol. 22: 886-900, 2002